These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32645429)

  • 1. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information.
    Gilmour N; Alépée N; Hoffmann S; Kern PS; Van Vliet E; Bury D; Miyazawa M; Nishida H; Cosmetics Europe
    ALTEX; 2023; 40(3):439-451. PubMed ID: 36919358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation risk assessment for skin sensitisation: A case study with propyl paraben.
    Assaf Vandecasteele H; Gautier F; Tourneix F; Vliet EV; Bury D; Alépée N
    Regul Toxicol Pharmacol; 2021 Jul; 123():104936. PubMed ID: 33905779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
    Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol.
    Gautier F; Tourneix F; Assaf Vandecasteele H; van Vliet E; Bury D; Alépée N
    Regul Toxicol Pharmacol; 2020 Nov; 117():104755. PubMed ID: 32800849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.
    Reynolds G; Reynolds J; Gilmour N; Cubberley R; Spriggs S; Aptula A; Przybylak K; Windebank S; Maxwell G; Baltazar MT
    Regul Toxicol Pharmacol; 2021 Dec; 127():105075. PubMed ID: 34728330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation risk assessment for skin allergy: Decision making using new approach methodologies.
    Gilmour N; Reynolds J; Przybylak K; Aleksic M; Aptula N; Baltazar MT; Cubberley R; Rajagopal R; Reynolds G; Spriggs S; Thorpe C; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Jun; 131():105159. PubMed ID: 35311660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitisation testing in practice: Applying a stacking meta model to cosmetic ingredients.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Ez-Zoubir M; Teissier SM; Noçairi H; Piroird C; Basketter D; Del Bufalo A
    Toxicol In Vitro; 2020 Aug; 66():104831. PubMed ID: 32198056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devising a Tier-based Skin Sensitisation Screening Strategy for Personal Care and Cosmetic Products.
    Fung ES; Towle KM; Monnot AD
    Altern Lab Anim; 2020 Mar; 48(2):70-77. PubMed ID: 32441989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitisation prediction using read-across, an illustrative next generation risk assessment (NGRA) case study for vanillin.
    Gautier F; Assaf Vandecasteele H; Tourneix F; van Vliet E; Alépée N; Bury D
    Regul Toxicol Pharmacol; 2023 Sep; 143():105458. PubMed ID: 37453556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.
    Basketter D; Beken S; Bender H; Bridges J; Casati S; Corvaro M; Cuvellier S; Hubesch B; Irizar A; Jacobs MN; Kern P; Lamplmair F; Manou I; Müller BP; Roggeband R; Rossi LH
    Regul Toxicol Pharmacol; 2020 Nov; 117():104767. PubMed ID: 32866543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
    Maxwell G; Aleksic M; Aptula A; Carmichael P; Fentem J; Gilmour N; Mackay C; Pease C; Pendlington R; Reynolds F; Scott D; Warner G; Westmoreland C
    Altern Lab Anim; 2008 Nov; 36(5):557-68. PubMed ID: 19025323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current opinion on risk assessment of cosmetics.
    Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
    J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of the Cosmetics Europe skin sensitisation database with new substances and PPRA data.
    Hoffmann S; Alépée N; Gilmour N; Kern PS; van Vliet E; Boislève F; Bury D; Cloudet E; Klaric M; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Tam Brami MT; Varçin M; Api AM; Europe C
    Regul Toxicol Pharmacol; 2022 Jun; 131():105169. PubMed ID: 35447229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment.
    Maxwell G; Aeby P; Ashikaga T; Bessou-Touya S; Diembeck W; Gerberick F; Kern P; Marrec-Fairley M; Ovigne JM; Sakaguchi H; Schroeder K; Tailhardat M; Teissier S; Winkler P
    ALTEX; 2011; 28(1):50-5. PubMed ID: 21311850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the predictive nature of the Genomic Allergen Rapid Detection (GARD) assay with mammalian assays in determining the skin sensitisation potential of agrochemical active ingredients.
    Masinja W; Elliott C; Modi S; Enoch SJ; Cronin MTD; McInnes EF; Currie RA
    Toxicol In Vitro; 2021 Feb; 70():105017. PubMed ID: 33038465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.
    Dent MP; Vaillancourt E; Thomas RS; Carmichael PL; Ouedraogo G; Kojima H; Barroso J; Ansell J; Barton-Maclaren TS; Bennekou SH; Boekelheide K; Ezendam J; Field J; Fitzpatrick S; Hatao M; Kreiling R; Lorencini M; Mahony C; Montemayor B; Mazaro-Costa R; Oliveira J; Rogiers V; Smegal D; Taalman R; Tokura Y; Verma R; Willett C; Yang C
    Regul Toxicol Pharmacol; 2021 Oct; 125():105026. PubMed ID: 34389358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus of classification trees for skin sensitisation hazard prediction.
    Asturiol D; Casati S; Worth A
    Toxicol In Vitro; 2016 Oct; 36():197-209. PubMed ID: 27458072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status.
    Bialas I; Zelent-Kraciuk S; Jurowski K
    Toxics; 2023 Apr; 11(4):. PubMed ID: 37112619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a systems biology approach to skin allergy risk assessment.
    Maxwell G; Mackay C
    Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.